<DOC>
	<DOCNO>NCT02494063</DOCNO>
	<brief_summary>To evaluate whether less radical surgical approach sentinel lymph node biopsy non-inferior treatment systematic pelvic lymphadenectomy . The null hypothesis recurrence rate SLN biopsy non-inferior reference recurrence rate 7 % ( 24th month follow-up ) patient systematic pelvic lymphadenectomy , less radical surgery associate significantly lower postoperative morbidity .</brief_summary>
	<brief_title>Sentinel Lymph Node Biopsy Patients With Early Stages Cervical Cancer</brief_title>
	<detailed_description>Patients enrol study time surgery planning ; point , patient´s consent request inclusion criterion fulfil ( histological type , FIGO stage , age , performance status , lymph node clinical status ) . The following procedure provide prior surgery : clinical staging ( MRI EUS ) , medical data collection , adverse event assessment , lymphedema assessment , quality life questionnaire , ECOG performance status , weight height , standard pre-operative laboratory workup , pregnancy test clinically indicate . Surgery do within 6 week image study ( MRI expert US ) . During surgery , local distant cancer spread outside cervix exclude , SLN detect , SLN send intra-operative pathologic evaluation . In patient SLN detection side pelvis lymph node remove continue study . SLN biopsy follow radical hysterectomy ( type B , C1 , C2 ) fertility-sparing procedure , accord pre-operative plan . Intra-operatively , follow patient exclude study , systematic pelvic lymphadenectomy perform side pelvis , treatment provide accord institutional guideline : 1 . Patients intra-operative detection advance disease stage ( &gt; IB1 ) 2 . Patients without bilateral SLN detection ( either SLN detect one side pelvis ) 3 . Patients intra-operative pathologic detection macrometastases micrometastases SLN Excluded patient remain database reason exclusion enter SIS ( Form 2 ) . In patient , continue study , SLNs process pathologist accord protocol SLN ultrastaging ( Chapter 7.4.2 ; Appendix 11 ) . If macrometastases micrometastases detect SLNs pathologic ultrastaging surgery , adjuvant radiotherapy recommend patient . No adjuvant treatment offer negative final lymph node status ITC ( Isolated Tumor Cells ) detection , confirm pre-operative disease FIGO stage ( IA1 - IB1 ) , adequately perform radical hysterectomy negative parametrial vaginal margin . Follow-up consist visit regular interval 6 month surgery ( additional visit shorter interval schedule accord institutional guideline ) . The following procedure provide visit follow-up period : pelvic examination , symptomatic lymphocele assessment , quality life assessment ( 6 12 month surgery ) , adverse event assessment , secondary low extremity lymphedema assessment ( 2 year surgery ) . Other image study do clinically indicate . Any postoperative complication disease recurrence manage accord institutional guideline .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>A ) Preoperative : 1 . FIGO stage IA1+LVSI ; IA2 ; IB1 2 . No evidence bulky suspicious pelvic lymph node distant metastasis preoperative conventional imaging study 3 . Performance status ECOG : 0 1 4 . Age ≥ 18 year , ≤ 75 year 5 . Squamous cell carcinoma OR Adenocarcinoma OR Adenosquamous carcinoma 6 . Suitable candidate primary surgical treatment : radical hysterectomy tumor ≤ 4 cm large diameter OR fertilitysparing treatment tumor ≤ 2 cm large diameter 7 . History second primary cancer &gt; 5 year evidence disease 8 . Approved sign Informed consent B ) Intraoperative 1 . Bilateral SLN detection 2 . Negative intraoperative pathologic SLN evaluation ( frozen section ) 3 . No intraoperative evidence advance disease ( &gt; IB1 ) 1 . Neoadjuvant chemotherapy 2 . Pregnancy 3 . History pelvic abdominal radiotherapy 4 . HIV positivity / AIDS</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>sentinel lymph node</keyword>
	<keyword>lymphadenectomy</keyword>
</DOC>